Nxera Sues Rival Biotech Over Drug Research Patent
Biopharma business Nxera has accused a rival of infringing its patents covering an engineered version of a protein used extensively in drug discovery research, arguing that the specific variants the biotech...To view the full article, register now.
Already a subscriber? Click here to view full article